covid cure? Algernon Pharmaceuticals Inc (CSE:AGN)
Post# of 714
Moreau, who will be speaking directly to investors at Proactive's One2One Investor Conference on July 28th at 1pm EST, says the company’s announcement of the study comes as it plans to launch a multinational Phase 2b/3 human trial of Ifenprodil as a potential therapeutic treatment for COVID-19 sufferers.
https://www.proactiveinvestors.com/companies/...24965.html
https://i.makeagif.com/media/12-01-2018/6WgD08.mp4